Yonqi Deng,Gerald W. Shipps, Jr.,Sie-Mun Lo,Liang Zhu,Alan B. Cooper,Kiran Muppalla
申请号：
US13819366
公开号：
US08946216B2
申请日:
2011.08.29
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention provides a compound of the Formula I: Formula I or a pharmaceutically acceptable salt, solvate or ester thereof, wherein R, R1, R2, R3, R4, X, m and n are as defined herein. The compounds are ERK inhibitors. Also disclosed are pharmaceutical compositions comprising the above compounds and methods of treating cancer using the same.
